The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

chief.ai

Stage

Grant | Alive

About Chief.AI

Chief.AI is a global AI resource that makes it easy to discover and consume artificial intelligence programmatically.

Chief.AI Headquarter Location

United Kingdom

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Chief.AI News

Pay-as-you-go AI platform launched through collaboration with Medicines Discovery Catapult

Jul 26, 2021

Pay-as-you-go AI platform launched through collaboration with Medicines Discovery Catapult 26 July 2021 × The project has been launched by Chief.AI with support from the Medicines Discovery Catapult and a grant from Innovate UK. Manchester-based service provider Chief.AI has developed a machine-learning operations (MLOps) platform that sources best-in-class AI models for SMEs, providing access to information, skills, resources and expertise. It is the first no-code service of its type within bioinformatics, meaning SMEs can build applications without the requirement of internal IT capabilities. Chief.AI is the latest platform within the life sciences industry to offer ways to utilise AI to speed up things like data analysis within drug discovery and clinical trials. In drug discovery, AI can be utilised to resolve issues that have previously existed in the industry. It could, for example, be used to analyse and predict the behaviour of molecules in the human body much earlier than traditional methods, which financially could save billions in research and development.the orchestration engine. Waqar Ali, founder of Chief.AI said: “As an orchestrator of AI, we are delighted to be able to make access to AI easier and more effective for healthcare providers around the world. Artificial intelligence will prove to be a great force multiplier for data intensive applications such as drug discovery and diagnostics, and with the help of the Medicines Discovery Catapult, Chief.AI is strategically poised to enable businesses around the world to connect to AI and reap these efficiencies seamlessly.” Prof. John P. Overington, chief informatics officer, Medicines Discovery Catapult, said: “This is a very exciting time for drug discovery. The development and utilisation of AI has been something that the industry has needed to propel that next step forward, and with Chief.AI it is now possible. AI is going to be something that will permeate across all aspects of society and business in the years to come and it is wonderful that we are able to offer this platform to UK SMEs, providing them with information and expertise which otherwise would have been inaccessible.”

  • What is Chief.AI's latest funding round?

    Chief.AI's latest funding round is Grant.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.